Hagen H. Kitzler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hagen H. Kitzler has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Bettina Beuthien-Baumann
OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
2 shared publications A. Hähner
Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
1 shared publication- A. Patterson
Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
1 shared publication - Alexander Schlaefer
Hamburg University of Technology
1 shared publication - Alexandra Prakapenia
Dresden Neurovascular Center, Department of Neurology, Dresden University of Technology, 01307 Dresden, Germany
1 shared publication - Ann-Christin Ostwaldt
Jung Diagnostics GmbH Hamburg Germany
1 shared publication
Latest Publications
- 1 September 2020
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 84, 101772
Multiple sclerosis lesion activity segmentation with attention-guided two-path CNNs
- 1 September 2020
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 84, 101772
Multiple sclerosis lesion activity segmentation with attention-guided two-path CNNs
- Open Access
- 8 July 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2148
Association of Hypertensive Intracerebral Hemorrhage with Left Ventricular Hypertrophy on Transthoracic Echocardiography
Introduction: Arterial hypertension is the most frequent cause for spontaneous intracerebral hemorrhage (sICH) and may also cause left ventricular hypertrophy (LVH). We sought to analyze whether hypertensive sICH etiology is associated with LVH. Methods: We analyzed consecutive patients with sICH who were admitted to our tertiary stroke center during a four-year period and underwent transthoracic echocardiography (TTE) as part of the diagnostic work-up. We defined hypertensive sICH as typical localization of hemorrhage in patients with arterial hypertension and no other identified sICH etiology. We defined an increased end-diastolic interventricular septal wall thickness of ≥11 mm on TTE as a surrogate parameter for LVH. Results: Among 395 patients with sICH, 260 patients (65.8%) received TTE as part of their diagnostic work-up. The median age was 71 years (interquartile range (IQR) 17), 160 patients (61.5%) were male, the median baseline National Institute of Health Stroke Scale (NIHSS) score was 8 (IQR 13). Of these, 159 (61.2%) patients had a hypertensive sICH and 156 patients (60%) had LVH. In univariable (113/159 (71.1%) vs. 43/101 (42.6%); odds ratio (OR) 3.31; 95% confidence interval (CI95%) 1.97–5.62); and multivariable (adjusted OR 2.95; CI95% 1.29–6.74) analysis, hypertensive sICH was associated with LVH. Conclusions: In patients with sICH, LVH is associated with hypertensive bleeding etiology. Performing TTE is meaningful for diagnosis of comorbidities and clarification of bleeding etiology in these patients. Future studies should include long-term outcome parameters and assess left ventricular mass as main indicator for LVH.
- 8 July 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2148
Open AccessAssociation of Hypertensive Intracerebral Hemorrhage with Left Ventricular Hypertrophy on Transthoracic Echocardiography
Introduction: Arterial hypertension is the most frequent cause for spontaneous intracerebral hemorrhage (sICH) and may also cause left ventricular hypertrophy (LVH). We sought to analyze whether hypertensive sICH etiology is associated with LVH. Methods: We analyzed consecutive patients with sICH who were admitted to our tertiary stroke center during a four-year period and underwent transthoracic echocardiography (TTE) as part of the diagnostic work-up. We defined hypertensive sICH as typical localization of hemorrhage in patients with arterial hypertension and no other identified sICH etiology. We defined an increased end-diastolic interventricular septal wall thickness of ≥11 mm on TTE as a surrogate parameter for LVH. Results: Among 395 patients with sICH, 260 patients (65.8%) received TTE as part of their diagnostic work-up. The median age was 71 years (interquartile range (IQR) 17), 160 patients (61.5%) were male, the median baseline National Institute of Health Stroke Scale (NIHSS) score was 8 (IQR 13). Of these, 159 (61.2%) patients had a hypertensive sICH and 156 patients (60%) had LVH. In univariable (113/159 (71.1%) vs. 43/101 (42.6%); odds ratio (OR) 3.31; 95% confidence interval (CI95%) 1.97–5.62); and multivariable (adjusted OR 2.95; CI95% 1.29–6.74) analysis, hypertensive sICH was associated with LVH. Conclusions: In patients with sICH, LVH is associated with hypertensive bleeding etiology. Performing TTE is meaningful for diagnosis of comorbidities and clarification of bleeding etiology in these patients. Future studies should include long-term outcome parameters and assess left ventricular mass as main indicator for LVH.
- Open Access
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 20, 61-70
Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 20, 61-70
Open AccessMulti-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion
- 1 September 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1053) , 20150354
Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults. The standard therapy for GBM is maximal surgical resection followed by radiotherapy with concurrent and adjuvant temozolomide (TMZ). In spite of the extensive treatment, the disease is associated with poor clinical outcome. Further intensification of the standard treatment is limited by the infiltrating growth of the GBM in normal brain areas, the expected neurological toxicities with radiation doses >60 Gy and the dose-limiting toxicities induced by systemic therapy. To improve the outcome of patients with GBM, alternative treatment modalities which add low or no additional toxicities to the standard treatment are needed. Many Phase II trials on new chemotherapeutics or targeted drugs have indicated potential efficacy but failed to improve the overall or progression-free survival in Phase III clinical trials. In this review, we will discuss contemporary issues related to recent technical developments and new metabolic strate...
- 1 September 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1053) , 20150354
Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults. The standard therapy for GBM is maximal surgical resection followed by radiotherapy with concurrent and adjuvant temozolomide (TMZ). In spite of the extensive treatment, the disease is associated with poor clinical outcome. Further intensification of the standard treatment is limited by the infiltrating growth of the GBM in normal brain areas, the expected neurological toxicities with radiation doses >60 Gy and the dose-limiting toxicities induced by systemic therapy. To improve the outcome of patients with GBM, alternative treatment modalities which add low or no additional toxicities to the standard treatment are needed. Many Phase II trials on new chemotherapeutics or targeted drugs have indicated potential efficacy but failed to improve the overall or progression-free survival in Phase III clinical trials. In this review, we will discuss contemporary issues related to recent technical developments and new metabolic strate...
- 30 January 2015
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 272 (11) , 3593-3594
Are small olfactory bulbs a risk for olfactory loss following an upper respiratory tract infection?
Considering the correlation between olfactory function and size of the human olfactory bulb (OB), it may be that OB volume is representative of the average number of functional olfactory receptor neurons in the nose. We observed a woman (64-year-old) with a 3-week history of hyposmia following an upper respiratory tract infection. Interestingly, both OB volumes were below the tenth percentile of the general population which seems to be difficult to explain by rapid, adaptive changes in the OB volume. It is hypothesized that small OBs may be a risk factor for acquiring olfactory loss.
- 30 January 2015
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 272 (11) , 3593-3594
Are small olfactory bulbs a risk for olfactory loss following an upper respiratory tract infection?
Considering the correlation between olfactory function and size of the human olfactory bulb (OB), it may be that OB volume is representative of the average number of functional olfactory receptor neurons in the nose. We observed a woman (64-year-old) with a 3-week history of hyposmia following an upper respiratory tract infection. Interestingly, both OB volumes were below the tenth percentile of the general population which seems to be difficult to explain by rapid, adaptive changes in the OB volume. It is hypothesized that small OBs may be a risk factor for acquiring olfactory loss.
- 1 July 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (7) , 1163-1168
FDG PET/MR for lymph node staging in head and neck cancer
- 1 July 2014
- Published by Elsevier in European Journal of Radiology
- Vol. 83 (7) , 1163-1168
FDG PET/MR for lymph node staging in head and neck cancer